Amount Raised
$100 Million
Round Type
Series C
WalthamBiotechnologyHealth CareMedicalTherapeuticsDescription
TScan Therapeutics, a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies in oncology, today announced the closing of an oversubscribed $100 million Series C financing. The financing round added new investors including funds and accounts managed by BlackRock, RA Capital Management, and two undisclosed healthcare-focused funds. Existing investors including founding investor Longwood Fund, 6 Dimensions Capital, Bessemer Venture Partners, GV, Novartis Venture Fund and Pitango HealthTech also participated in the round. Proceeds from this financing will be used to advance TScan’s TCR-T cell therapy pipeline for solid and liquid tumors into the clinic.
Quick answer
TScan Therapeutics, Inc. raised $100 Million in a Series C round, dated January 25, 2021. TScan Therapeutics, Inc. is based in Waltham, Massachusetts, United States.
- How much did TScan Therapeutics, Inc. raise?
- TScan Therapeutics, Inc. raised $100 Million in a Series C round on January 25, 2021.
- What does TScan Therapeutics, Inc. do?
- TScan Therapeutics is an experienced group of scientists, development specialists, and other leaders driving a cutting edge platform
- Where is TScan Therapeutics, Inc. based and how big is it?
- TScan Therapeutics, Inc. is based in Waltham, Massachusetts, United States.
- Who are the decision-makers at TScan Therapeutics, Inc?
- Fundz holds 1 contact at TScan Therapeutics, Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as TScan Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Acrivon Therapeutics raised $16M on February 12, 2021.
- Faeth Therapeutics raised $30M (Funding Round) on January 11, 2021.
- Scorpion Therapeutics raised $162M (Series B) on January 7, 2021.
- Immuneering raised $37M on January 5, 2021.
- DTx Pharma, Inc. raised $100M on March 10, 2021.
- MapLight Therapeutics raised $30M on March 10, 2021.
Who to call at TScan Therapeutics, Inc., and when
A new round usually means TScan Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day TScan Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TScan Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TScan Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TScan Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
TScan Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.